These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12607389)

  • 21. Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation.
    Calcaianu G; Canuet M; Schuller A; Enache I; Chaouat A; Kessler R
    Respiration; 2016; 91(1):9-17. PubMed ID: 26492415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral prostacyclin therapy for pulmonary arterial hypertension: another step forward.
    Waxman AB
    Circulation; 2013 Feb; 127(5):563-5. PubMed ID: 23307828
    [No Abstract]   [Full Text] [Related]  

  • 23. Improving care for patients with pulmonary hypertension: comment on "Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study".
    Redberg RF
    JAMA Intern Med; 2013 May; 173(10):893. PubMed ID: 23568571
    [No Abstract]   [Full Text] [Related]  

  • 24. Epoprostenol and nitric oxide therapy for severe pulmonary hypertension in liver transplantation.
    Molmenti EP; Ramsay M; Ramsay K; Lynch K; Tillmann Hein HA; Molmenti H; Levy M; Goldstein R; Ausloos K; East C; Fasola C; Jung G; Escobar J; Klintmalm G
    Transplant Proc; 2001; 33(1-2):1332. PubMed ID: 11267313
    [No Abstract]   [Full Text] [Related]  

  • 25. Has the 6-min walk distance run its course?
    McLaughlin VV
    Chest; 2012 Dec; 142(6):1363-1365. PubMed ID: 23208324
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pulmonary arterial hypertension in connective tissue diseases].
    Degano B
    Rev Mal Respir; 2006 Dec; 23(6):746-8. PubMed ID: 17886350
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic management of primary pulmonary hypertension].
    Chaouat A; Weitzenblum E
    Presse Med; 2002 Feb; 31(7):320-8. PubMed ID: 11899690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
    Humbert M
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
    [No Abstract]   [Full Text] [Related]  

  • 29. [Is pulmonary hypertension diagnosed correctly and early enough? Highly relevant dilemma: incomplete diagnostic, inaccurate treatment].
    Rosenkranz S
    Dtsch Med Wochenschr; 2013 Sep; 138(37):1820. PubMed ID: 24006160
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pulmonary hypertension].
    Kovacs G; Olschewski H
    Dtsch Med Wochenschr; 2012 Oct; 137(40):2026-8. PubMed ID: 23023615
    [No Abstract]   [Full Text] [Related]  

  • 31. [Current issues in pulmonary hypertension].
    Forster T
    Orv Hetil; 2012 Apr; 153(16):603-6. PubMed ID: 22510315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in prostacyclin therapy for pulmonary arterial hypertension.
    Eells PL
    Crit Care Nurse; 2004 Apr; 24(2):42-8, 50-4. PubMed ID: 15098310
    [No Abstract]   [Full Text] [Related]  

  • 33. Identical twins with primary pulmonary hypertension: beraprost vs epoprostenol.
    Berman Rosenzweig E; Schmitt KA; Garofano R; Barst RJ
    Chest; 2004 Mar; 125(3):1157-60. PubMed ID: 15006984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical management of primary pulmonary hypertension.
    McLaughlin VV
    Expert Opin Pharmacother; 2002 Feb; 3(2):159-65. PubMed ID: 11829729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new era in the treatment of primary pulmonary hypertension.
    Bailey CL; Channick RN; Rubin LJ
    Heart; 2001 Mar; 85(3):251-2. PubMed ID: 11179256
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug therapy for pulmonary arterial hypertension: what's on the menu today?
    Mehta S
    Chest; 2003 Dec; 124(6):2045-9. PubMed ID: 14665473
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
    Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pulmonary hypertension: the issues of diagnosis and treatment].
    Sakalauskas R; Barkauskiene D; Vebriene J; Sadauskas S
    Medicina (Kaunas); 2004; 40(10):1019-25. PubMed ID: 15516828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacological and clinical profile of treprostinil (TREPROST® for injection)].
    Saito R; Ohmori Y
    Nihon Yakurigaku Zasshi; 2016 Jan; 147(1):56-62. PubMed ID: 26753860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.